Publications - 'N'
Publications 576 - 600 de 978
| Titre | DOI |
|---|---|
|
Nivolumab (nivo) +/- ipilimumab (ipi) in pre-treated patients with advanced, refractory pulmonary or gastroenteropancreatic poorly differentiated neuroendocrine tumors (NECs) (GCO-001 NIPINEC) N. Girard; J. Mazieres; J. Otto; H. Lena; C. Lepage; T. Egenod; D. Smith; J. Madelaine; L. Geriniere; E. Hajbi; A. Ferru; C. Clement-Duchene; A. Madroszyk; J. Desrame; F. Morin; A. Langlais; P. Michel; C. Louvet; V. Westeel; T. Walter 2021 |
10.1016/j.annonc.2021.08.2119 |
|
Nivolumab versus docetaxel in previously treated advanced non-small-cell lung cancer (CheckMate 017 and CheckMate 057): 3-year update and outcomes in patients with liver metastases E.E. Vokes; N. Ready; E. Felip; L. Horn; M.A. Burgio; S.J. Antonia; A. Frontera; S. Gettinger; E. Holgado; D. Spigel; D. Waterhouse; M. Domine; M. Garassinoio; L.Q.M. Chow; ; F. Barlesi; B. Coudert; J. Gainor; O. Arrieta; J. Brahmer; C. Butts; M. Steins; W.J. Geese; A. Li; D. Healey; L. Crino 2018 |
10.1093/annonc/mdy041 |
|
NK cells and Lipoxin A(4) promote resolution of eosinophilic inflammation after nasal allergen challenge A. Poirot; G. Wacht; C. Lehalle; P. Saas; N. Frossard; B. Geny; F. De Blay; C. Barnig 2022 |
10.1111/all.15103 |
|
NKp30 isoforms and NKp30 ligands are predictive biomarkers of response to imatinib mesylate in metastatic GIST patients S. Rusakiewicz; A. Perier; M. Semeraro; J.M. Pitt; E.Pogge von Strandmann; K.S. Reiners; S. Aspeslagh; C. Piperoglou; F. Vely; A. Ivagnes; S. Jegou; N. Halama; L. Chaigneau; P. Validire; C. Christidis; T. Perniceni; B. Landi; A. Berger; N. Isambert; J. Domont; S. Bonvalot; P. Terrier; J. Adam; J.M. Coindre; J.F. Emile; V. Poirier-Colame; K. Chaba; B. Rocha; A. Caignard; A. Toubert; D. Enot; J. Koch; A. Marabelle; M. Lambert; S. Caillat-Zucman; S. Leyvraz; C. Auclair; E. Vivier; A. Eggermont; C. Borg; J.Y. Blay; A. Le Cesne; O. Mir; L. Zitvogel 2017 |
10.1080/2162402X.2015.1137418 |
|
Nlrp3 Gene Expression in Circulating Leukocytes Declines During Healthy Aging J.L. Connat; A. Dumont; M. Rialland; B. Faivre; G. Sorci 2018 |
10.1093/gerona/gly018 |
|
NLRP3 inflammasome-mediated cytokine production and pyroptosis cell death in breast cancer S.Socorro Faria; S. Costantini; V.Claudio Co de Lima; V.Pianna de Andrade; M. Rialland; R. Cedric; A. Budillon; K.Grace Magalhaes 2021 |
10.1186/s12929-021-00724-8 |
|
NO and cancer: itinerary of a double agent S. Plenchette; S. Romagny; V. Laurens; A. Bettaieb 2016 |
10.1051/medsci/20163206027 |
|
No arbitrage of the first kind and local martingale numeraires Y. Kabanov; C. Kardaras; S. Song 2016 |
10.1007/s00780-016-0310-6 |
|
NO DIFFUSE HEPATIC STEATOSIS IN TYPE 1 DIABETIC PATIENTS RECEIVING INTRAPERITONEAL INSULINOTHERAPY S. Baillot-Rudoni; J.M. Petit; P. Buffier; A. Farret; B. Bouillet; G. Valliant; B. Verges 2014 |
|
|
NO DIFFUSE HEPATIC STEATOSIS IN TYPE 1 DIABETIC PATIENTS RECEIVING INTRAPERITONEAL INSULINOTHERAPY S. Baillot-Rudoni; J.M. Petit; P. Buffier; A. Farret; B. Bouillet; G. Valliant; B. Verges 2014 |
|
|
No effect of fampridine on real-life physical activity in people with multiple sclerosis Y. Sagawa; E. Watelain; T. Moulin; P. Decavel 2018 |
10.1016/j.rehab.2017.10.006 |
|
No effect of vancomycin MIC >= 1.5 mg/L on treatment outcome in methicillin-susceptible Staphylococcus aureus bacteraemia K. Bouiller; C. Laborde; S.Ludwig Aho; D. Hocquet; A. Pechinot; V. Le Moing; X. Bertrand; L. Piroth; C. Chirouze 2018 |
10.1016/j.ijantimicag.2017.12.028 |
|
No evidence for prezygotic postcopulatory avoidance of kin despite high inbreeding depression P. Vuarin; A. Bouchard; L. Lesobre; G. Leveque; T. Chalah; M.Saint Jalme; F. Lacroix; Y. Hingrat; G. Sorci 2018 |
10.1111/mec.14951 |
|
No Evidence for the Benefit of Gonadotropin-Releasing Hormone Agonist in Preserving Ovarian Function and Fertility in Lymphoma Survivors Treated With Chemotherapy: Final Long-Term Report of a Prospective Randomized Trial I. Demeestere; P. Brice; F.A. Peccatori; A. Kentos; J. Dupuis; P. Zachee; O. Casasnovas; E. Van Den Neste; J. Dechene; V. De Maertelaer; D. Bron; Y. Englert 2016 |
10.1200/JCO.2015.65.8864 |
|
No evidence of an immune adjustment in response to a parasitoid threat in Lobesia botrana larvae F. Vogelweith; Y. Moret; D. Thiery; L. Delbac; J. Moreau 2017 |
10.1016/j.jinsphys.2017.08.010 |
|
No evidence of hepatitis B virus reactivation among liver transplant recipients treated with interferon- free regimens for hepatitis C virus recurrence (ANRS CO23 CUPILT Cohort) L. Mouna; E. Rossignol; M. Tateo; J.C. Duclos-Vallee; C. Duvoux; F. Durand; A. Tran; S. Radenne; V. Canva-Delcambre; P. Houssel-Debry; J. Dumortier; F. Conti; V. de Ledinghen; V. Leroy; N. Kamar; V. Di Martino; C. Moreno; D.M.Botta Fridlund; L. d'Alteroche; P. Lebray; P. Perre; C. Besch; C. Silvain; F. Habersetzer; M. Debette-Gratien; A. Abergel; A. Diallo; A.Marie Roque-Afonso; G.P. Pageaux 2017 |
|
|
No evidence of neurocognitive adverse events associated with alirocumab treatment in 3340 patients from 14 randomized Phase 2 and 3 controlled trials: a meta-analysis of individual patient data P.D. Harvey; M.N. Sabbagh; J.E. Harrison; H.N. Ginsberg; J. Chapman; G. Manvelian; A. Moryusef; J. Mandel; M. Farnier 2018 |
10.1093/eurheartj/ehx661 |
|
No evidence of SARS-CoV-2 transfusion transmission despite RNA detection in blood donors showing symptoms after donation P. Cappy; D. Candotti; V. Sauvage; Q. Lucas; L. Boizeau; J. Gomez; V. Enouf; L. Chabli; J. Pillonel; P. Tiberghien; P. Morel; S. Laperche 2020 |
10.1182/blood.2020008230 |
|
No impact of a prescription booklet on medication consumption in nursing home residents from 2011 to 2014: a controlled before-after study S. Sanchez; C. Payet; M. Herr; F. Ecarnot; C. Blochet; D. Armaingaud; J. Chrusciel; J.L. Novella; R. Mahmoudi 2021 |
10.1007/s40520-020-01670-5 |
|
No impact of sub-clinical coronary artery disease identified by cardiac CT scan on the recurrence of atrial fibrillation after a single ablation procedure S. Sakhy; R. Didier; M. Blain; T. Leclercq; M. Maza; A. Artus; R. Issa; M. Zeller; A. Cochet; Y. Cottin; G. Laurent Submitted |
10.1007/s10840-021-01018-7 |
|
No Improvement of Hepatitis B Vaccination Response in Patients Dialysed with a Polymethylmethacrylate Membrane Compared to High-Flux Polysulfone: Results of the HEPADIAL Study V. de Precigout; C. Germain; A. Benard; A. Lacraz; P. Chauveau; C. Deprele; B. Seigneuric; A. Pommereau; C. Courivaud; M. Douillet; B. Taton; C. Combe; C. Contin-Bordes 2020 |
10.1159/000504035 |
|
No Improvement of High-Density Lipoprotein (HDL) Vasorelaxant Effect Despite Increase in HDL Cholesterol Concentration in Type 2 Diabetic Patients Treated With Glitazones L. Persegol; L. Duvillard; S. Monier; M.C. Brindisi; B. Bouillet; J.M. Petit; B. Verges 2014 |
10.1210/jc.2014-2078 |
|
No Major Effect of Cyclosporin A in Patients with Severe Solar Urticaria: A French Retrospective Case Series C. Hurabielle; C. Bedane; M. Avenel-Audran; H. Adamski; F. Aubin; M. Jeanmougin; M.C. Marguery; J.L. Peyron; C. Poreaux; J.L. Schmutz; M. Viguier; S.Francaise Photodermatologie 2015 |
10.2340/00015555-2140 |
|
No need for a social cue! A masked magician can also trick the audience in the vanishing ball illusion C. Thomas; A. Didierjean 2016 |
10.3758/s13414-015-1036-9 |
|
No need to learn from each other? - Potentials of Knowledge Modeling in Autonomous Vehicle Systems Engineering Towards new methods in multidisciplinary contexts F. Schaefer; R. Kriesten; D. Chrenko; A. Ravey; F. Gechter 2017 |